169 related articles for article (PubMed ID: 18346400)
1. Naftifine: a review.
Gupta AK; Ryder JE; Cooper EA
J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
[TBL] [Abstract][Full Text] [Related]
2. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
Monk JP; Brogden RN
Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
[TBL] [Abstract][Full Text] [Related]
3. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
Del Rosso JQ; Kircik LH
J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
[TBL] [Abstract][Full Text] [Related]
4. Naftifine: a topical allylamine antifungal agent.
Mühlbacher JM
Clin Dermatol; 1991; 9(4):479-85. PubMed ID: 1822408
[No Abstract] [Full Text] [Related]
5. Naftifine: A Topical Allylamine for Superficial Dermatophytosis.
Trailokya AA; Shirsat AB; Madhu R; Shah B
J Assoc Physicians India; 2023 May; 71(5):11-12. PubMed ID: 37355825
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
[TBL] [Abstract][Full Text] [Related]
7. Naftifine, a topical allylamine.
Marks S; Cantrell W; Varma R; Elewski B
J Drugs Dermatol; 2010 Jul; 9(7):750. PubMed ID: 20677526
[No Abstract] [Full Text] [Related]
8. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
[TBL] [Abstract][Full Text] [Related]
9. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
Zaun H; Luszpinski P
Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
[TBL] [Abstract][Full Text] [Related]
11. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
[TBL] [Abstract][Full Text] [Related]
12. Naftifine cream in the treatment of cutaneous candidiasis.
Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J
Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
[TBL] [Abstract][Full Text] [Related]
13. Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes.
Vago T; Baldi G; Colombo D; Barbareschi M; Norbiato G; Dallegri F; Bevilacqua M
Antimicrob Agents Chemother; 1994 Nov; 38(11):2605-11. PubMed ID: 7872755
[TBL] [Abstract][Full Text] [Related]
14. Naftifine treatment of resistant dermatophytosis.
Rosen T; Fischer M; Orengo I; Abuabara F
Int J Dermatol; 1991 Aug; 30(8):590-2. PubMed ID: 1938060
[TBL] [Abstract][Full Text] [Related]
15. Overview of topical therapy for common superficial fungal infections and the role of new topical agents.
Brennan B; Leyden JJ
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S3-8. PubMed ID: 9039198
[TBL] [Abstract][Full Text] [Related]
16. Allylamine antifungal drugs.
Ryder NS; Mieth H
Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066
[No Abstract] [Full Text] [Related]
17. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.
Petranyi G; Ryder NS; Stütz A
Science; 1984 Jun; 224(4654):1239-41. PubMed ID: 6547247
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the allylamines.
Birnbaum JE
J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):782-5. PubMed ID: 2229523
[TBL] [Abstract][Full Text] [Related]
19. [Contact allergy to the antifungal agent naftifin].
Hoting E; Küchmeister B; Hausen BM
Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
[TBL] [Abstract][Full Text] [Related]
20. Naftifine versus miconazole/hydrocortisone in inflammatory dermatophyte infections.
Nada M; Hanafi S; al-Omari H; Mokhtar M; el-Shamy S; Mühlbacher J
Int J Dermatol; 1994 Aug; 33(8):570-2. PubMed ID: 7960355
[No Abstract] [Full Text] [Related]
[Next] [New Search]
